Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1993 Jan;142(1):329–337.

Centrocytic lymphoma: a morphometric study with comparison to other small cleaved follicular center cell lymphomas and genotypic correlates.

S H Swerdlow 1, M H Saboorian 1, R J Pelstring 1, M E Williams 1
PMCID: PMC1886829  PMID: 8424464

Abstract

Centrocytic lymphoma (ML,CC) is distinguished from other cleaved follicular center cell (FCC) lymphomas in the Kiel classification by the lack of noncleaved FCC and not by morphological differences between the centrocytes (cleaved cells). Immunophenotypic and genotypic studies, however, have shown that the centrocytes in ML,CC are distinct from those of other small cleaved FCC lymphomas (ML,FCC,SC). To morphologically compare the cells of ML,CC with nine previously studied ML,FCC,SC and to relate the findings in ML,CC to the varied descriptions of lymphomas of intermediate differentiation, a morphometric analysis of 22 ML,CC was performed. Nuclei in ML,CC were, on average, significantly larger, rounder, and had less frequent nucleoli than those in ML,FCC,SC; however, the proportion of small round lymphocytes did not differ. Among the ML,CC, the only apparent immunophenotypic/genotypic correlate that was identified was greater nuclear ellipticity for the biopsies lacking chromosome 11q13 bcl-1 or PRAD1 rearrangement. Repeat biopsies in four patients with ML,CC showed an increase in nuclear size. These data demonstrate that a lack of transformed cells is not the only morphological difference between ML,CC and ML,FCC,SC. The morphological distinction, however, is not based on the proportion of small round lymphocytes present. In addition, the morphometric parameters illustrate the nuclear variability among ML,CC and demonstrate how the disease may evolve over time.

Full text

PDF
329

Images in this article

332Figure 2
on p.332
332Figure 3
on p.332
335Figure 5
on p.335
335Figure 6
on p.335

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Lardelli P., Bookman M. A., Sundeen J., Longo D. L., Jaffe E. S. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol. 1990 Aug;14(8):752–763. doi: 10.1097/00000478-199008000-00007. [DOI] [PubMed] [Google Scholar]
  2. Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer. 1974 Oct;34(4 Suppl):suppl–suppl:1503. doi: 10.1002/1097-0142(197410)34:8+<1488::aid-cncr2820340822>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  3. Medeiros L. J., Van Krieken J. H., Jaffe E. S., Raffeld M. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood. 1990 Nov 15;76(10):2086–2090. [PubMed] [Google Scholar]
  4. Oudemans P. B., Brutel de la Rivière G., Hart G. A., van Heerde P., Scholte G., Vroom T. M. Determination of transferrin receptors on frozen sections of malignant B-cell lymphomas by immunofluorescence with a monoclonal antibody. Cancer. 1986 Sep 15;58(6):1252–1259. doi: 10.1002/1097-0142(19860915)58:6<1252::aid-cncr2820580613>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  5. Pelstring R. J., Swerdlow S. H. Improved nuclear contour indices for lymphoid morphometry. Anal Quant Cytol Histol. 1987 Dec;9(6):469–474. [PubMed] [Google Scholar]
  6. Pelstring R. J., Swerdlow S. H. Morphometric analysis of follicular center cells: a new approach. Mod Pathol. 1988 Jul;1(4):262–267. [PubMed] [Google Scholar]
  7. Perry D. A., Bast M. A., Armitage J. O., Weisenburger D. D. Diffuse intermediate lymphocytic lymphoma. A clinicopathologic study and comparison with small lymphocytic lymphoma and diffuse small cleaved cell lymphoma. Cancer. 1990 Nov 1;66(9):1995–2000. doi: 10.1002/1097-0142(19901101)66:9<1995::aid-cncr2820660925>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  8. Pileri S., Rivano M. T., Gobbi M., Taruscio D., Lennert K. Neoplastic and reactive follicles within B-cell malignant lymphomas. A morphological and immunological study of 30 cases. Hematol Oncol. 1985 Oct-Dec;3(4):243–260. doi: 10.1002/hon.2900030404. [DOI] [PubMed] [Google Scholar]
  9. Rosenberg C. L., Wong E., Petty E. M., Bale A. E., Tsujimoto Y., Harris N. L., Arnold A. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9638–9642. doi: 10.1073/pnas.88.21.9638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Swerdlow S. H., Habeshaw J. A., Murray L. J., Dhaliwal H. S., Lister T. A., Stansfeld A. G. Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse. Am J Pathol. 1983 Nov;113(2):181–197. [PMC free article] [PubMed] [Google Scholar]
  11. Swerdlow S. H., Murray L. J., Habeshaw J. A., Stansfeld A. G. B- and T-cell subsets in follicular centroblastic/centrocytic (cleaved follicular center cell) lymphoma: an immunohistologic analysis of 26 lymph nodes and three spleens. Hum Pathol. 1985 Apr;16(4):339–352. doi: 10.1016/s0046-8177(85)80228-8. [DOI] [PubMed] [Google Scholar]
  12. Swerdlow S. H., Pelstring R. J., Collins R. D. Morphometric analysis of follicular center cell lymphomas. Am J Pathol. 1990 Oct;137(4):953–963. [PMC free article] [PubMed] [Google Scholar]
  13. Tolksdorf G., Stein H., Lennert K. Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes). Br J Cancer. 1980 Feb;41(2):168–182. doi: 10.1038/bjc.1980.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Weisenburger D. D., Nathwani B. N., Diamond L. W., Winberg C. D., Rappaport H. Malignant lymphoma, intermediate lymphocytic type: a clinicopathologic study of 42 cases. Cancer. 1981 Sep 15;48(6):1415–1425. doi: 10.1002/1097-0142(19810915)48:6<1415::aid-cncr2820480625>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  15. Weiss L. M., Warnke R. A., Sklar J., Cleary M. L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987 Nov 5;317(19):1185–1189. doi: 10.1056/NEJM198711053171904. [DOI] [PubMed] [Google Scholar]
  16. Williams M. E., Meeker T. C., Swerdlow S. H. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood. 1991 Jul 15;78(2):493–498. [PubMed] [Google Scholar]
  17. Williams M. E., Swerdlow S. H., Rosenberg C. L., Arnold A. Characterization of chromosome 11 translocation breakpoints at the bcl-1 and PRAD1 loci in centrocytic lymphoma. Cancer Res. 1992 Oct 1;52(19 Suppl):5541s–5544s. [PubMed] [Google Scholar]
  18. Williams M. E., Westermann C. D., Swerdlow S. H. Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood. 1990 Oct 1;76(7):1387–1391. [PubMed] [Google Scholar]
  19. van der Valk P., Mosch A., Kurver P. J., Meijer C. J. Morphometric characterisation of 52 B cell non-Hodgkin's lymphomas. J Clin Pathol. 1983 Mar;36(3):289–297. doi: 10.1136/jcp.36.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES